Avonex®: Safety, Blood Levels and Effects
NCT01863069
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
77
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis (MS)
Interventions
DRUG:
Interferon beta 1a
DRUG:
(IM) AVONEX®
Sponsor
Trio Medicines Ltd.
Collaborators
[object Object]